Australia's Labor government under pressure to fast-track medical innovation funding as Trump cuts US research.
Independent MP Monique Ryan has called on the Albanese administration to release more of the $20 billion Medical Research Future Fund (MRFF) earnings, urging them to take advantage of a growing vacuum in cutting-edge medical research caused by US President Donald Trump's slashing of government-funded research in the country. The fund's average annual rate of return has outperformed its benchmark since 2015 and Ryan believes increasing the annual disbursement amount would boost life-saving innovation.
Research by the Parliamentary Budget Office indicates that the MRFF's total value will grow to at least $30.1 billion over a decade, assuming an annual release of just $1 billion for research funding. Ryan argues that this could secure the future of Australia's research sector and deliver better health outcomes for all Australians.
The push for more funding has been backed by leading research organizations, including the Group of Eight universities, the Association of Australian Medical Research Institutes, and the Australian Academy of Health and Medical Sciences. A delegation visiting Parliament House on Thursday includes representatives from several top research institutions, highlighting the urgent need for increased support.
Ryan's concerns echo Trump's own moves to slash funding and staff appointments at the US Centers for Disease Control (CDC). The US president has replaced experienced scientists with loyalists and individuals without medical or scientific training. Australian researchers have had long-standing links to trusted US health institutions, including the CDC, which are now under threat.
The survival of world-class research institutes in Australia is also at risk. The Australian Association of Medical Research Institutes reported that many of its member organizations would cease to be financially viable within five years without more support. Ryan will highlight several research proposals that have been denied funding, including a clinical trial on pregnancy for women with sleep apnea and a study on the management of post-traumatic amnesia.
The establishment of an Australian Centre for Disease Control is close to being passed by parliament, but Ryan's calls for increased MRFF funding remain unanswered. The government must act quickly to address the growing vacuum in medical research caused by Trump's cuts and ensure that Australia continues to be a leader in life-saving innovation.
Independent MP Monique Ryan has called on the Albanese administration to release more of the $20 billion Medical Research Future Fund (MRFF) earnings, urging them to take advantage of a growing vacuum in cutting-edge medical research caused by US President Donald Trump's slashing of government-funded research in the country. The fund's average annual rate of return has outperformed its benchmark since 2015 and Ryan believes increasing the annual disbursement amount would boost life-saving innovation.
Research by the Parliamentary Budget Office indicates that the MRFF's total value will grow to at least $30.1 billion over a decade, assuming an annual release of just $1 billion for research funding. Ryan argues that this could secure the future of Australia's research sector and deliver better health outcomes for all Australians.
The push for more funding has been backed by leading research organizations, including the Group of Eight universities, the Association of Australian Medical Research Institutes, and the Australian Academy of Health and Medical Sciences. A delegation visiting Parliament House on Thursday includes representatives from several top research institutions, highlighting the urgent need for increased support.
Ryan's concerns echo Trump's own moves to slash funding and staff appointments at the US Centers for Disease Control (CDC). The US president has replaced experienced scientists with loyalists and individuals without medical or scientific training. Australian researchers have had long-standing links to trusted US health institutions, including the CDC, which are now under threat.
The survival of world-class research institutes in Australia is also at risk. The Australian Association of Medical Research Institutes reported that many of its member organizations would cease to be financially viable within five years without more support. Ryan will highlight several research proposals that have been denied funding, including a clinical trial on pregnancy for women with sleep apnea and a study on the management of post-traumatic amnesia.
The establishment of an Australian Centre for Disease Control is close to being passed by parliament, but Ryan's calls for increased MRFF funding remain unanswered. The government must act quickly to address the growing vacuum in medical research caused by Trump's cuts and ensure that Australia continues to be a leader in life-saving innovation.